News Medical on MSN9h
HIV drug access remains a major challenge despite promising trial resultsPromising new drugs to prevent and treat HIV have the potential to transform the response to the disease. But getting these ...
Wesley Sundquist’s lab laid foundation for development of a highly effective, long-lasting preventive measure against HIV.
A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.
The US drug administration has approved the use of the medication as an injection for use against the multidrug resistant ...
A Guideline Development Group (GDG) meeting at the end of the month aims to establish new guidelines for lenacapavir, a twice ...
The post appears to reference the drug lenacapavir, which reportedly can cost around $40,000 annually in the U.S. and is administered in twice-yearly doses. While the drug appears to be effective ...
Lenacapavir, approved by the US FDA, presents a groundbreaking advancement in the battle against HIV. Developed by Gilead ...
In Donald Trump’s 2019 State of the Union Address, he made “a commitment to eliminate the HIV epidemic in the United States ...
11don MSNOpinion
This year saw several advancements across medicine, space technology, and AI that extend our knowledge in consequential ways.
We came across a bullish thesis on Gilead Sciences, Inc. (NASDAQ:GILD) on Substack by Magnus Ofstad. In this article, we will ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback